SENZAR ASSET MANAGEMENT, LLC - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 93 filers reported holding ACELRX PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 2.60 and the average weighting 0.2%.

Quarter-by-quarter ownership
SENZAR ASSET MANAGEMENT, LLC ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2015$3,385,000
-15.7%
798,381
-23.3%
0.58%
-40.7%
Q1 2015$4,017,000
-34.2%
1,040,681
+14.8%
0.98%
-45.3%
Q4 2014$6,103,000
+100.7%
906,781
+63.7%
1.79%
+100.6%
Q3 2014$3,041,000
+51.7%
553,892
+183.2%
0.89%
+16.4%
Q2 2014$2,005,000195,6000.77%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q2 2014
NameSharesValueWeighting ↓
Monashee Investment Management LLC 1,652,190$3,817,0002.58%
LINCOLN CAPITAL CORP 62,000$143,0000.13%
Laurion Capital Management LP 1,944,727$4,492,0000.08%
Cedar Wealth Management, LLC 46,395$107,0000.08%
Fosun International Ltd 301,708$709,0000.04%
BCWM, LLC 35,100$811,0000.04%
Engineers Gate Manager LP 170,800$395,0000.03%
Alpine Global Management, LLC 45,211$104,0000.03%
MOORE CAPITAL MANAGEMENT, LP 250,000$578,0000.02%
SECTORAL ASSET MANAGEMENT INC 73,778$170,0000.02%
View complete list of ACELRX PHARMACEUTICALS INC shareholders